Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 13.39 | N/A |
| PEG Ratio (TTM) | 0.13 | N/A |
| P/S Ratio (TTM) | N/A | N/A |
| P/B Ratio (TTM) | 1.32 | N/A |
| P/FCF Ratio (TTM) | -353.29 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 9.43% | N/A |
| ROE (TTM) | 10.05% | N/A |
| Net Profit Margin (TTM) | N/A | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -1.43% | N/A | N/A |
| Revenue | N/A | N/A | N/A |
| Net Income | -2.51% | N/A | N/A |
| Cash Flow | -278.66% | N/A | N/A |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.43 | N/A |
| Quick Ratio (TTM) | 2.43 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | 0.21 | N/A |
| Piotroski F-Score | 2 | N/A |
| Altman Z-Score | 19.13 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |